Literature DB >> 11287287

Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa.

N Tanaka1, T Odajima, M Mimura, K Ogi, H Dehari, Y Kimijima, G Kohama.   

Abstract

We previously reported that pRb2/p130 gene, one of the Rb family members, was immunohistochemically abundantly expressed in well-differentiated oral squamous cell carcinomas, whereas in undifferentiated ones the expression was low. Oral malignant melanoma is extremely rare, however the prognosis is poor because it tends to locally invade tissue or metastasize and its biological behavior appears to be different from cutaneous malignant melanoma. The present study dealt with the expression of pRb2/p130, Rb, p53, and p16 in 13 cases of malignant melanoma of oral mucosa as revealed by immunohistochemical staining. The stage classification of the 13 patients was as follows; stage II: eight patients, stage III: three patients, and stage IV: two patients. pRb2/p130 was expressed in only two stage II-cases, neither of which have shown any evidence of recurrence or metastasis for over 14 years. Positive staining for Rb was found in three cases consisting of one stage II-case, one stage III-case, and one stage IV-case. p53 was expressed in two cases, one a stage II and the other a stage IV. Positive staining for p16 was found in seven cases consisting of four stage II-cases, two stage III-cases, and one stage IV-case. pRb2/p130 may be inversely correlated with the malignancy of oral malignant melanoma, but further study is needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287287     DOI: 10.1016/s1368-8375(00)00107-x

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck.

Authors:  Manju L Prasad; Snehal G Patel; Jatin P Shah; Stacy Hoshaw-Woodard; Klaus J Busam
Journal:  Head Neck Pathol       Date:  2011-12-13

2.  Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma.

Authors:  Bruno Augusto Benevenuto de Andrade; Jorge Esquiche León; Román Carlos; Wilson Delgado-Azañero; Adalberto Mosqueda-Taylor; Oslei Paes de Almeida
Journal:  Head Neck Pathol       Date:  2012-02-05

3.  Genetic markers of oral malignant melanoma analysed by fluorescence in situ hybridisation (FISH).

Authors:  Chiara Baldovini; Anna L Tosi; Enrico Di Oto; Camilla Reggiani; Susanna Cappia; Christine M Betts; Carmine Gallo; Lisa Ricchieri; Roberto Cocchi; Maria P Foschini
Journal:  Virchows Arch       Date:  2011-06-29       Impact factor: 4.064

Review 4.  Update on primary head and neck mucosal melanoma.

Authors:  Fernando López; Juan P Rodrigo; Antonio Cardesa; Asterios Triantafyllou; Kenneth O Devaney; William M Mendenhall; Missak Haigentz; Primož Strojan; Phillip K Pellitteri; Carol R Bradford; Ashok R Shaha; Jennifer L Hunt; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

5.  Oral and cutaneous melanoma: similarities and differences.

Authors:  Rafaela Nogueira Moreira; Cassio Roberto Rocha Santos; Nadia Lages Lima; Flaviana Dornela Verli; Sandra Aparecida Marinho
Journal:  J Clin Med Res       Date:  2010-08-18

Review 6.  RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.

Authors:  Paola Indovina; Francesca Pentimalli; Nadia Casini; Immacolata Vocca; Antonio Giordano
Journal:  Oncotarget       Date:  2015-07-20

7.  Targeting cyclin-dependent kinase 4/6 as a therapeutic approach for mucosal melanoma.

Authors:  Chao-Ji Shi; Sheng-Ming Xu; Yong Han; Rong Zhou; Zhi-Yuan Zhang
Journal:  Melanoma Res       Date:  2021-12-01       Impact factor: 3.599

8.  Oral amelanotic melanoma.

Authors:  A O Adisa; W O Olawole; O F Sigbeku
Journal:  Ann Ib Postgrad Med       Date:  2012-06

9.  Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.

Authors:  Changlei Yao; Hongfa Li; Weitao Zhang
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Mar-Dec       Impact factor: 3.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.